A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.

Journal: Thrombosis research
Published Date:

Abstract

INTRODUCTION: The 10th revision of the International Classification of Diseases (ICD-10) codes is frequently used to identify pulmonary embolism (PE) events, although the validity of ICD-10 has been questioned. Natural language processing (NLP) is a novel tool that may be useful for pulmonary embolism identification.

Authors

  • Stacy A Johnson
    Division of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America; Thrombosis Service, University of Utah Health, Salt Lake City, UT, United States of America. Electronic address: stacy.a.johnson@hsc.utah.edu.
  • Emily A Signor
    Division of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America; Thrombosis Service, University of Utah Health, Salt Lake City, UT, United States of America.
  • Katie L Lappe
    Division of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America; Thrombosis Service, University of Utah Health, Salt Lake City, UT, United States of America.
  • Jianlin Shi
    University of Utah, Salt Lake City, UT, USA.
  • Stephen L Jenkins
    Division of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America; Thrombosis Service, University of Utah Health, Salt Lake City, UT, United States of America.
  • Sara W Wikstrom
    Division of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
  • Rachel D Kroencke
    Division of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America; Thrombosis Service, University of Utah Health, Salt Lake City, UT, United States of America.
  • David Hallowell
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
  • Aubrey E Jones
    University of Utah, College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, United States of America; University of Utah, School of Medicine, Department of Population Health, Salt Lake City, UT, United States of America.
  • Daniel M Witt
    Thrombosis Service, University of Utah Health, Salt Lake City, UT, United States of America; University of Utah, College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, United States of America.